Sale!

UPB1 Gene Beta-Ureidopropionase Deficiency Genetic Test

Original price was: $700.Current price is: $500.

-29%

The UPB1 Gene Beta-Ureidopropionase Deficiency NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the UPB1 gene responsible for beta-ureidopropionase deficiency, a rare metabolic disorder affecting pyrimidine metabolism. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of genetic variants that can cause neurological symptoms, developmental delays, and metabolic abnormalities. The test is particularly valuable for individuals with unexplained neurological symptoms, developmental concerns, or family history of metabolic disorders. At only $500 USD, this advanced genetic testing offers early intervention opportunities, personalized treatment strategies, and valuable information for family planning decisions. Results are typically available within 3-4 weeks from sample collection.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

UPB1 Gene Beta-Ureidopropionase Deficiency NGS Genetic DNA Test

Comprehensive Genetic Testing for Metabolic Disorders

The UPB1 Gene Beta-Ureidopropionase Deficiency NGS Genetic DNA Test represents a significant advancement in the diagnosis and management of rare metabolic disorders. This specialized genetic test focuses on identifying mutations in the UPB1 gene, which encodes the enzyme beta-ureidopropionase. This enzyme plays a crucial role in the final step of pyrimidine degradation, and its deficiency can lead to serious neurological and developmental complications if left undiagnosed.

What This Test Measures and Detects

Our advanced NGS-based genetic test specifically targets the UPB1 gene to identify pathogenic variants that cause beta-ureidopropionase deficiency. The test examines:

  • Complete coding regions of the UPB1 gene
  • Exon-intron boundaries for splice site mutations
  • Known pathogenic variants associated with the disorder
  • Novel mutations that may affect enzyme function
  • Both homozygous and compound heterozygous mutations

Who Should Consider This Test

This genetic test is particularly recommended for individuals presenting with:

  • Unexplained neurological symptoms including seizures or movement disorders
  • Developmental delays or intellectual disability of unknown origin
  • Abnormal urinary organic acid profiles suggestive of pyrimidine metabolism disorders
  • Family history of beta-ureidopropionase deficiency or related metabolic conditions
  • Consanguineous parents or family history suggesting autosomal recessive inheritance
  • Unexplained metabolic acidosis or other biochemical abnormalities

Key Benefits of UPB1 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Provides definitive diagnosis for individuals with suspected beta-ureidopropionase deficiency
  • Early Intervention: Enables timely implementation of appropriate dietary and therapeutic interventions
  • Family Planning: Offers crucial information for genetic counseling and reproductive decision-making
  • Personalized Treatment: Guides development of targeted treatment strategies based on specific genetic findings
  • Prognostic Information: Helps predict disease progression and potential complications
  • Research Contribution: Contributes to ongoing research and understanding of rare metabolic disorders

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your results effectively:

  • Positive Result: Indicates the presence of pathogenic mutations in the UPB1 gene, confirming beta-ureidopropionase deficiency diagnosis
  • Negative Result: Suggests that no known pathogenic variants were detected, though clinical correlation remains essential
  • Variant of Uncertain Significance (VUS): Identifies genetic changes whose clinical significance requires further investigation
  • Carrier Status: Determines if an individual carries one copy of a mutated gene, important for family planning

Test Details and Pricing

Test Feature Details
Test Name UPB1 Gene Beta-Ureidopropionase Deficiency NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session prior to testing
  • Development of detailed family pedigree chart
  • Discussion of potential implications and limitations of testing
  • Informed consent process

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and healthcare professionals ensures accessible, high-quality genetic testing services nationwide.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about metabolic disorders affect your health decisions. Our UPB1 Gene Beta-Ureidopropionase Deficiency NGS Genetic DNA Test provides the clarity and confidence you need for informed healthcare choices. With our discounted price of $500 USD and comprehensive genetic counseling support, you can access world-class genetic testing without financial burden.

Ready to schedule your test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take control of your genetic health with confidence and precision.